Zanubrutinib for treating Waldenstrom’s macroglobulinaemia

Supporting evidence

• Evaluation report

• Final appraisal determination committee papers (PDF 1.85 MB)

  Published:

  19 October 2022

• Appraisal consultation committee papers 1 (PDF 9.87 MB)

  Published:

  19 October 2022

• Appraisal consultation committee papers 2 (PDF 1.01 MB)

  Published:

  19 October 2022